Composition
- Active ingredients
- CISATRACURIUM BESYLATE EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020551.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Nimbex
- Active substance
- cisatracurium besylate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Abbvie
- Status
- Discontinued
- FDA approval
- 15 Dec 1995
- Application
- NDA020551-001